Comparison of DBFS with MoCA and MMSE tools for MCI screening

Eun Yip Chad Chew1, Pillay Prem1, Kuah Jasmine1

  • 1Neurowyzr Pte. Ltd., 6 Raffles Quay, 11-07, Singapore-048580.

Bioinformation
|October 27, 2023
PubMed

Insights

The Digital Brain Function Screen (DBFS) shows promise for early mild cognitive impairment (MCI) detection. This digital tool correlates well with traditional tests, offering a potential improvement for cognitive assessment.

Area of Science:

  • Neurology
  • Gerontology
  • Digital Health

Background:

  • Mild cognitive impairment (MCI) is linked to various diseases and can indicate early-stage conditions.
  • Early detection of MCI is crucial for interventions aimed at restoring cognitive function.
  • Traditional screening tools for MCI have limitations.

Purpose of the Study:

  • To evaluate the efficacy of the Digital Brain Function Screen (DBFS) as a tool for detecting mild cognitive impairment (MCI).
  • To compare the performance of the DBFS against established cognitive assessment tools.

Main Methods:

  • One hundred and five subjects were assessed using the Digital Brain Function Screen (DBFS) and Montreal Cognitive Assessment (MoCA).
  • Seventy-three subjects also completed the Mini-Mental State Examination (MMSE).
  • Test-retest reliability was assessed in 16 subjects using the DBFS.

Main Results:

  • The DBFS demonstrated a significant positive correlation with both MoCA and MMSE scores.
  • The digital tool showed good reliability in test-retest assessments.

Conclusions:

  • The Digital Brain Function Screen (DBFS) is a potentially effective digital tool for screening mild cognitive impairment (MCI).
  • DBFS may overcome the limitations associated with traditional MCI screening methods like MoCA and MMSE.